Search

everythinglearnresearchcommunity

for

Search:↓

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

The circadian clock is crucial for tissue renewal and regeneration, affecting stem cell functions and having implications for health and disease.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Muscles and nerves that cause goosebumps also help control hair growth.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

The conclusion is that hair growth can be improved by activating hair cycles, changing the surrounding environment, healing wounds to create new hair follicles, and using stem cell technology.

Fetal skin cells from a cell bank heal wounds faster and with less scarring than adult cells.

Researchers found 63 genes linked to male-pattern baldness, which could help in understanding its biology and developing new treatments.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Hair loss in balding individuals is linked to changes in specific hair growth-related genes.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Future research on ectodysplasin should explore its role in diseases, stem cells, and evolution, and continue developing treatments for genetic disorders like hypohidrotic ectodermal dysplasia.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.